Joint venture potential The company is the US arm of a 2024 joint venture between Steelco and Belimed, signaling a strategic alignment that may open cross-sell opportunities for integrated reprocessing and sterilization solutions, bundled services, and shared technology platforms.

Endoscope reprocessing expansion Recent launch of Steri Case expands the endoscope washing and liquid chemical sterilization portfolio with continuous leak test control, creating upsell and replacement cycle opportunities for facilities upgrading or expanding infection prevention and workflow automation.

Moderate revenue growth potential With estimated revenue of 25 to 50 million and a mid-market headcount profile, there is room to target mid-to-large healthcare and medical device customers seeking scalable sterilization and sterilization-related services within North America.

Sustainability and compliance Adoption of ISO 14001 and other sustainability-minded tech stack elements indicate a client-led emphasis on environmental management, offering a pathway to position energy efficiency, waste reduction, and compliant equipment upgrades as value drivers.

Strategic partnerships Existing collaboration between Steelco and Belimed suggests openness to partner ecosystems; sales teams can pursue channel partnerships, integrators, and hospital GPOs to broaden penetration in sterilization and endoscope reprocessing segments.